News releases - Merck.com
Oct 28, 2024 · Merck Announces Third-Quarter 2024 Financial Results. October 28, 2024. Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination …
Merck Announces Third-Quarter 2024 Financial Results
Oct 31, 2024 · This news release of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the …
KOSELUGO® (selumetinib) Showed Significant and Clinically ... - Merck
1 day ago · This news release of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. …
Merck to Present New Data From GARDASIL®9 Studies …
2 days ago · This news release of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. …
MRK - | Stock Price & Latest News | Reuters
1 day ago · Get Merck & Co Inc (MRK) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.
Merck Enters Two Strategic Collaborations to Strengthen AI …
Sep 20, 2023 · Merck, a leading science and technology company, today announced two new strategic drug discovery collaborations aimed at harnessing powerful artificial intelligence (AI) …
Merck (MRK) earnings Q2 2024 - CNBC
Jul 30, 2024 · Merck on Tuesday reported second-quarter revenue and adjusted earnings that topped Wall Street’s expectations as it saw strong sales from its blockbuster cancer drug …
With 79% ownership, Merck & Co., Inc. (NYSE:MRK) boasts of …
1 day ago · The company's largest shareholder is The Vanguard Group, Inc., with ownership of 9.7%. With 8.2% and 4.6% of the shares outstanding respectively, BlackRock, Inc. and State …
Merck buys cancer therapy developer Modifi Biosciences for up to …
Oct 23 (Reuters) - Merck (MRK.N) has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm said on...
Merck sees Gardasil China woes carrying into 2025 - Yahoo Finance
Oct 31, 2024 · MRK. By Michael Erman and Leroy Leo. (Reuters) -Merck & Co said on Thursday that weak sales of Gardasil in China are likely to carry over into 2025 as the vaccine's …
- Some results have been removed